E
Jade Biosciences, Inc. JBIO
$8.03 $0.131.65% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025
Total Cash And Short-Term Investments 342.51%
Total Receivables --
Inventory --
Prepaid Expenses 163.48%
Finance Division Loans and Leases Current --
Total Finance Division Other Current Assets --
Other Current Assets --
Total Current Assets 339.78%

Total Current Assets 339.78%
Net Property, Plant & Equipment 20.78%
Long-term Investments --
Goodwill --
Total Other Intangibles --
Finance Div Loans & Leases LT --
Total Finance Div Other LT Assets --
Total Other Assets -98.76%
Total Assets 297.64%

Total Accounts Payable 79.98%
Total Accrued Expenses 6.93%
Short-term Debt --
Current Portion of Long-Term Debt/Capital Leases --
Finance Division Debt Current --
Total Finance Division Other Current Liabilities 74.49%
Total Other Current Liabilities 74.49%
Total Current Liabilities 34.71%

Total Current Liabilities 34.71%
Long-Term Debt --
Short-term Debt --
Capital Leases 1.15%
Finance Division Debt Non Current --
Total Finance Division Other Non Current Liabilities --
Total Other Liabilities --
Total Liabilities -83.97%

Common Stock & APIC 19,366.54%
Retained Earnings -37.74%
Treasury Stock & Other --
Total Common Equity 341.36%

Preferred Stock Redeemable --
Preferred Stock Non Redeemable --
Preferred Stock Convertible --
Preferred Stock, Others --
Total Preferred Equity --

Total Common Equity 341.36%
Total Preferred Equity --
Total Minority Interest --
Total Equity 341.36%